These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Enduracidin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity. Tsuchiya K; Kondo M; Oishi T; Yamazaki I J Antibiot (Tokyo); 1968 Feb; 21(2):147-53. PubMed ID: 4386300 [No Abstract] [Full Text] [Related]
24. Clinical outcome of pneumococcal bacteremia, in vitro resistance, and antibiotic therapy. Torres-Tortosa M; Caballero-Granado J; Canueto J; Moreno-Maqueda I Clin Infect Dis; 2004 Mar; 38(5):763-4; author reply 765-6. PubMed ID: 14986265 [No Abstract] [Full Text] [Related]
25. [Use of the automated system for bacteriological diagnosis of suppurative complications]. Imshenetskaia VF Antibiot Khimioter; 1990 Oct; 35(10):41-3. PubMed ID: 2278498 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of cefazolin in the treatment of bacterial endocarditis and bacteremia. Reinarz JA; Kier CM; Guckian JC J Infect Dis; 1973 Oct; 128():Suppl:S392-6. PubMed ID: 4147580 [No Abstract] [Full Text] [Related]
27. [Bacteriological study on clindamycin-2-palmitate (author's transl)]. Ono H; Otsuki M; Nakazawa S Jpn J Antibiot; 1973 Aug; 26(4):321-4. PubMed ID: 4582578 [No Abstract] [Full Text] [Related]
28. Immunological investigations in experimental chemotherapy. I. The susceptibility of mice to homologous re-infection following antibacterial treatment. Sackmann W Chemotherapy; 1966; 11(2):86-94. PubMed ID: 4380957 [No Abstract] [Full Text] [Related]
29. [Bacterial hospitalism in the light of current knowledge on the origin and mechanism of antibiotic resistance]. Lebek G Med Monatsschr; 1970 Apr; 24(4):142-5. PubMed ID: 5485956 [No Abstract] [Full Text] [Related]
31. [Experiences with lincomycin from the clinic and laboratory]. Vacek V; Hejzlar M Arzneimittelforschung; 1966 Dec; 16(12):1600-6. PubMed ID: 4385186 [No Abstract] [Full Text] [Related]
33. [Lincomycin in the treatment of gram positive infections]. Ramirez Aznar G Prensa Med Mex; 1968; 33(1):44-6. PubMed ID: 5760269 [No Abstract] [Full Text] [Related]
34. [Use of furagin in treatment of urinary tract infections]. Mis M; Boian M; Lente I; Shari B; Boda Z Ter Arkh; 1978; 50(2):119-23. PubMed ID: 25493 [No Abstract] [Full Text] [Related]
35. [Apropos of 220 strains of Streptococcus isolated in hospital blood cultures. Study of the bactericidal action of antibiotics and their associations]. Christol D; Boussougant Y; Bure AM; Witchitz J; Zribi A; Dupuis M Lyon Med; 1971; 225():Suppl:99-108. PubMed ID: 5564800 [No Abstract] [Full Text] [Related]
36. [The effect of combinations of antibacterial preparations on resistant strains of pyelonephritis agents]. Sukhodol'skaia AE; Chaĭkovskaia VL Antibiotiki; 1974 Jul; 19(7):630-3. PubMed ID: 4618771 [No Abstract] [Full Text] [Related]
37. Cross resistance between lincomycin and erythromycin in viridans streptococci. Sprunt K; Leidy G; Redman W Pediatrics; 1970 Jul; 46(1):84-8. PubMed ID: 5423461 [No Abstract] [Full Text] [Related]
38. [Therapy results with nalidixic acid in chronic urinary tract infection]. Broghammer H Arzneimittelforschung; 1968 Sep; 18(9):1139-43. PubMed ID: 4885373 [No Abstract] [Full Text] [Related]
39. [Antibiotic microbial resistance surveillance in invasive infections caused by Streptococcus pneumoniae and Staphylococcus aureus: the EARSS (European Antimicrobial Resistance Surveillance System) project in Italy (April 1999-April 2000)]. Moro ML; Pantosti A; Boccia D; Ann Ig; 2002; 14(5):361-71. PubMed ID: 12508445 [TBL] [Abstract][Full Text] [Related]
40. Enhancement of host defense mechanisms against gram-positive pyogenic coccal infections with levo-tetramisole (levamisole) in neonatal rats. Fisher GW; Oi VT; Kelley JL; Podgore JK; Bass JW; Wagner FS; Gordon BL Ann Allergy; 1974 Oct; 33(4):193-8. PubMed ID: 4413243 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]